News and Updates

Explore the Latest from Sensus Healthcare

Discover the latest top news articles from Sensus Healthcare. Stay informed about our groundbreaking advancements, treatment breakthroughs, and industry insights. Explore our curated selection of articles and navigate through them using the pagination feature below

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million

Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million

Is Mohs Surgery the Best Treatment Option for You?

Superficial Radiotherapy: A Brief Introduction

Sensus Healthcare Reports Third Quarter 2023 Financial Results

Sensus Healthcare Reports Third Quarter 2023 Financial Results

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.